ELLINGTON MANAGEMENT GROUP LLC - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 107 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2019. The put-call ratio across all filers is 3.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
ELLINGTON MANAGEMENT GROUP LLC ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2019$113,000
-6.6%
20,700
-16.9%
0.02%
+9.1%
Q3 2019$121,000
-27.5%
24,900
+3.3%
0.02%
-24.1%
Q2 2019$167,000
-16.1%
24,100
-16.0%
0.03%
-19.4%
Q1 2019$199,000
+57.9%
28,700
+38.6%
0.04%
+300.0%
Q1 2018$126,00020,7000.01%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q4 2019
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$27,550,00020.34%
AdvisorShares Investments LLC 380,750$2,079,0001.29%
ETF MANAGERS GROUP, LLC 5,779,642$31,557,0001.10%
DAFNA Capital Management LLC 297,300$1,623,0000.56%
GENERAL AMERICAN INVESTORS CO INC 632,400$3,453,0000.32%
Aries Wealth Management 27,900$160,0000.10%
Virtus ETF Advisers LLC 81,751$446,0000.07%
Omnia Family Wealth, LLC 21,726$119,0000.06%
HighVista Strategies LLC 12,200$67,0000.05%
WOODSTOCK CORP 57,213$312,0000.05%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders